메뉴 건너뛰기




Volumn 67, Issue 3, 2004, Pages 293-307

Comparing systems for costing hospital treatments: The case of stable angina pectoris

Author keywords

Activity based costing; Cost systems; DRG; Reimbursement; Stable angina pectoris

Indexed keywords

ARTICLE; CONTROLLED STUDY; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL CHARGE; HOSPITAL COST; HOSPITAL FINANCE; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; REIMBURSEMENT; STABLE ANGINA PECTORIS;

EID: 1242292454     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2003.07.004     Document Type: Article
Times cited : (9)

References (25)
  • 3
    • 0001397063 scopus 로고
    • Conditions under which activity-based cost systems provide relevant costs
    • Noreen E. Conditions under which activity-based cost systems provide relevant costs. Journal of Management Accounting Research 1991. p. 159-68.
    • (1991) Journal of Management Accounting Research , pp. 159-168
    • Noreen, E.1
  • 4
    • 85030901546 scopus 로고    scopus 로고
    • Ministry of Health
    • Ministry of Health 1999. Http://www.info.sum.dk/drg/dsi/dsidok.html .
    • (1999)
  • 6
    • 43949152635 scopus 로고
    • Are overhead costs strictly proportional to activity? Evidence from hospital service departments
    • Noreen E., Soderstrom N. Are overhead costs strictly proportional to activity? Evidence from hospital service departments. Journal of Accounting & Economics. 17(3):1994;255-278.
    • (1994) Journal of Accounting & Economics , vol.17 , Issue.3 , pp. 255-278
    • Noreen, E.1    Soderstrom, N.2
  • 8
    • 0002313337 scopus 로고    scopus 로고
    • Product costing in the presence of endogenous subcost functions
    • Christensen J., Demski J. Product costing in the presence of endogenous subcost functions. Review of Accounting Studies. 2(1):1997;65-87.
    • (1997) Review of Accounting Studies , vol.2 , Issue.1 , pp. 65-87
    • Christensen, J.1    Demski, J.2
  • 11
    • 85030902465 scopus 로고    scopus 로고
    • Hvad koster patienten? Introduktion til DSI projektet 'patientrelaterede omkostninger
    • (in Danish)
    • Knudsen M. Hvad koster patienten? Introduktion til DSI projektet 'patientrelaterede omkostninger. Tidsskrift for dansk sundhedsvæsen. 72(5):1996;198-201. (in Danish).
    • (1996) Tidsskrift for Dansk Sundhedsvæsen , vol.72 , Issue.5 , pp. 198-201
    • Knudsen, M.1
  • 12
    • 1242311089 scopus 로고    scopus 로고
    • Hvad er Diagnose-Relaterede-Grupper (DRG)?
    • (in Danish)
    • Nielsen K. Hvad er Diagnose-Relaterede-Grupper (DRG)? Ugeskrift for læger. 158(23):1996;3374-3383. (in Danish).
    • (1996) Ugeskrift for Læger , vol.158 , Issue.23 , pp. 3374-3383
    • Nielsen, K.1
  • 13
    • 0031531309 scopus 로고    scopus 로고
    • Hospital reimbursement incentives: An empirical analysis
    • McClellan M. Hospital reimbursement incentives: an empirical analysis. Journal of Economics and Management Strategy. 6(1):1997;91-128.
    • (1997) Journal of Economics and Management Strategy , vol.6 , Issue.1 , pp. 91-128
    • McClellan, M.1
  • 15
    • 85030892644 scopus 로고    scopus 로고
    • Takstsystem 2000 vejledning. København: Nyt Nordisk Forlag Arnold Busck A/S, 2000. (in Danish)
    • The Danish Ministry of Health. Takstsystem 2000 vejledning. København: Nyt Nordisk Forlag Arnold Busck A/S, 2000. (in Danish).
  • 18
    • 0031919805 scopus 로고    scopus 로고
    • Costs and effects in therapy of acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasticy in the EPIC study
    • Hout v. B.A., Bowman L., Zelinger D.J., Simoons M.L. Costs and effects in therapy of acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasticy in the EPIC study. European Heart Journal. 19(Supp D):1998;59-66.
    • (1998) European Heart Journal , vol.19 , Issue.SUPP D , pp. 59-66
    • Hout V., B.A.1    Bowman, L.2    Zelinger, D.J.3    Simoons, M.L.4
  • 21
    • 0029918451 scopus 로고    scopus 로고
    • Cost-effectiveness of coronary angioplasticy versus medical treatment: The impact of cost-shifting
    • Kinlay S. Cost-effectiveness of coronary angioplasticy versus medical treatment: the impact of cost-shifting. Australian and New Zealand Journal of Medicine. 26:1996;20-26.
    • (1996) Australian and New Zealand Journal of Medicine , vol.26 , pp. 20-26
    • Kinlay, S.1
  • 22
    • 0030064941 scopus 로고    scopus 로고
    • Comparison of percutaneous transluminal coronary angioplasty outcome and hospital costs for low-volume and high-volume operators
    • Shook T.L., Sun G.-W., Burstein S., Eisenhauer A.C., Matthews R.V. Comparison of percutaneous transluminal coronary angioplasty outcome and hospital costs for low-volume and high-volume operators. American Journal of Cardiology. 77:1996;331-336.
    • (1996) American Journal of Cardiology , vol.77 , pp. 331-336
    • Shook, T.L.1    Sun, G.-W.2    Burstein, S.3    Eisenhauer, A.C.4    Matthews, R.V.5
  • 24
    • 0028840219 scopus 로고
    • A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST)
    • Weintraub W.S., Maulden P.D., Becker E., Kosinski A.S., King S.B. Jr. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation. 92:1995;2831-2840.
    • (1995) Circulation , vol.92 , pp. 2831-2840
    • Weintraub, W.S.1    Maulden, P.D.2    Becker, E.3    Kosinski, A.S.4    King, S.B.Jr.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.